سعر راميبريل كومب ال اس 2.5/12.5مجم 7 اقراص 2022

Ramipril 2.5 mg + hydrochlorothiazide 12.5 mg tablets by Pharopharma (Egypt), a fixed-dose antihypertensive combination.

• Treatment of hypertension in patients whose blood pressure is not adequately controlled with ramipril alone or hydrochlorothiazide alone.Population: AdultsSwedish Medical Products Agency (Läkemedelsverket, MPA)

• Common: headache, dizziness; persistent dry cough (ramipril).International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)
• Other reported effects include myocardial ischaemia, tachycardia, palpitations, blood-count decreases, visual disturbance, and (not known frequency) non-melanoma skin cancer with hydrochlorothiazide.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)

• Hypersensitivity to ramipril, other ACE inhibitors, hydrochlorothiazide, other thiazides, sulphonamides or excipients.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)
• History of angioedema (hereditary, idiopathic or with ACE inhibitors/AIIRAs).International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)
• Significant bilateral renal artery stenosis or stenosis in a single functioning kidney; severe renal impairment (CrCl <30 mL/min) in undialysed patients.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)

• Serious adverse reactions include angioedema or anaphylactic reactions, renal or hepatic impairment, pancreatitis, severe skin reactions and neutropenia/agranulocytosis.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)
• Hydrochlorothiazide may worsen glucose, lipid and uric acid metabolism; the two components have opposite effects on plasma potassium.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)
• Hypotension may occur at initiation in diuretic-treated patients; consider reducing or stopping the diuretic first.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)

• Contraindicated during breast-feeding; both substances are excreted in human milk and thiazides may suppress lactation.International label, same formulation · Swedish Medical Products Agency (Läkemedelsverket, MPA)